Most of research activity in the biomedical area is either fundamental or translational. Translational meanings that the goal of your research is to at some point improve health care and medicine.
However, the road from the lab to the actual use of your research in real life is paved with obstacles. The application of your research ends up as a blurry objective, something you mention in publications, without knowing how it could actually become a new treatment or a novel diagnostic tool.
It is true that the obstacles in the biomedical field are bigger than in the other fields. The clinical trials are expensive, with a low success ratio, very long time before bringing profit which makes investment risky and thus hard to get! But on the other hand, it’s becoming more and more clear that despite those obstacles, the investment risk can be overcome and the reward is even bigger!
Nowadays, more and more European and national organizations understand the potential of biotech companies and propose funding schemes to raise your translational research.
This webinar co-organised by the MCAA France Chapter and the YEBN, aims to present you how you can transform your biomedical research in a company. Introducing you examples of Startup accelerator programs and testimony of former researchers that created their startup.